Clinical Trial Update: The Clinical Study to Evaluate the Efficacy and Safety of Fimasartan in Patients With Mild to Moderate Essential Hypertension [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the efficacy and safety of fimasartan in mild to moderate essential hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Fimasartan (fimasartan)

Snippet

Sponsor: Boryung Pharmaceutical Co., Ltd | Conditions: Hypertension | Phase 3 | Status: COMPLETED